ADAR-mediated RNA editing of DNA:RNA hybrids is required for DNA double strand break repair

Jimeno, Sonia; Prados-Carvajal, Rosario; Fernández-Ávila, María Jesús; Silva, Sonia; Silvestris, Domenico Alessandro; Endara-Coll, Martín; Rodríguez-Real, Guillermo; Domingo-Prim, Judit; Mejías-Navarro, Fernando; Romero-Franco, Amador; Jimeno-González, Silvia; Barroso, Sonia; Cesarini, Valeriana; Aguilera, Andrés; Gallo, Angela; Visa, Neus; Huertas, Pablo

doi:10.1038/s41467-021-25790-2

Download PDF

Article
Open access
Published: 17 September 2021

ADAR-mediated RNA editing of DNA:RNA hybrids is required for DNA double strand break repair

Nature Communications volume 12, Article number: 5512 (2021) Cite this article

12k Accesses
26 Citations
86 Altmetric
Metrics details

Subjects

Abstract

The maintenance of genomic stability requires the coordination of multiple cellular tasks upon the appearance of DNA lesions. RNA editing, the post-transcriptional sequence alteration of RNA, has a profound effect on cell homeostasis, but its implication in the response to DNA damage was not previously explored. Here we show that, in response to DNA breaks, an overall change of the Adenosine-to-Inosine RNA editing is observed, a phenomenon we call the RNA Editing DAmage Response (REDAR). REDAR relies on the checkpoint kinase ATR and the recombination factor CtIP. Moreover, depletion of the RNA editing enzyme ADAR2 renders cells hypersensitive to genotoxic agents, increases genomic instability and hampers homologous recombination by impairing DNA resection. Such a role of ADAR2 in DNA repair goes beyond the recoding of specific transcripts, but depends on ADAR2 editing DNA:RNA hybrids to ease their dissolution.

Improving prime editing with an endogenous small RNA-binding protein

Article Open access 03 April 2024

DNA double-strand break–capturing nuclear envelope tubules drive DNA repair

Article 17 April 2024

Genome engineering with Cas9 and AAV repair templates generates frequent concatemeric insertions of viral vectors

Article 08 April 2024

Introduction

Cells are continuously challenged by DNA damage. Among all kinds of insults that a DNA molecule has to deal with, double-strand breaks (DSBs) are the most dangerous. Indeed, just one unrepaired DSB is enough to either kill or terminally arrest cells. For these reasons when DSBs are formed, a complex cellular response—the DNA damage response (DDR)—is triggered in order to ensure the proper repair of such a threat to genomic integrity¹.

There are several pathways that can be used in order to repair a DSB and the choice between them is highly regulated. A eukaryotic cell can repair a DSB either by the simple re-ligation of the DNA ends (a process known as Non-Homologous End-Joining, NHEJ)² or by a homology-driven repair event. There are different routes among the repair pathways that use homologous regions for repair, all of which are grouped in a process called homologous recombination (HR)³. All HR events share a first biochemical step called DNA resection, which is the key to decide the pathway that will be eventually used to repair the DSB^4,5. This process consists of the nucleolytic degradation of the DNA ends of the break that produces tails of 3' ended single-stranded DNA (ssDNA), that are rapidly protected by the RPA protein complex.

In recent years, the importance of RNA and RNA-related factors in DNA repair has become clear^6,7,8,9. Indeed, many RNA-related proteins have been shown to be targets of the DNA damage-induced post-translational modifications^10,11,12. Also, direct roles of specific RNA-related factors in DNA repair have been recently reported (for a review see⁹). Moreover, the RNA molecule itself seems to impact DNA repair. Several labs have shown the formation of DNA:RNA hybrids around DSBs in different eukaryotes, either dependent on previous transcription^13,14 or upon de novo transcription of the broken chromatin^15,16. The relevance of such RNA molecules is still under debate, with both pro- and anti-repair effects ascribed to them⁹.

An important co-transcriptional RNA modification that, so far, has not been extensively studied in its putative relationship with DNA repair and the response to DNA damage is RNA editing. This process alters RNA sequences by the action of specific deaminases that convert one base into another. Every mammalian transcript can be subjected to RNA editing^17,18,19. RNA editing can be classified into several categories²⁰, including adenosine-to-inosine (A-to-I) deamination, which is accomplished by a family of RNA-specific adenosine deaminases known as ADARs^18,19. This family is formed by ADAR1, ADAR2 (also known as ADARB1), and ADAR3; however, only ADAR1 and ADAR2 have been shown to present catalytic activity. A-to-I deamination is the most abundant form of RNA-editing in mammals and defects in this process are associated with human diseases, such as disorders of the central nervous system²¹ or pediatric astrocytomas²². Only limited information has been published regarding the connection of A-to-I editing and DNA damage, albeit at least the mRNA of NEIL1, has been shown to be re-coded by ADAR1 to alter its enzymatic properties²³. Moreover, A-to-I editing has been proposed to be involved in the pathogenesis of cancer^24,25.

Here, we show that the general pattern of ADAR2-mediated A-to-I editing changes upon DSB formation. Such changes depend on the DDR, specifically the ATR kinase and the resection protein CtIP. As a consequence, ADAR2 is required for the maintenance of genomic integrity and, specifically for DNA end resection and HR. Strikingly, mRNAs from either resection-related or recombination-related genes are not affected by ADAR2. Instead, ADAR2 role in resection is related to its ability to edit DNA:RNA hybrids. Not only do such structures increase when ADAR2 is depleted, but this protein physically and functionally interacts with the BRCA1-SETX complex for this role.

Results

RNA editing changes after DNA damage

As previously mentioned, crosstalk between RNA metabolism and DNA repair has been extensively documented⁹, but a connection between DNA repair and RNA editing has not been extensively analyzed. Thus, we wanted to study whether the appearance of DNA damage had any effect on RNA editing. In order to explore this possibility, we used a previously published reporter system (RNAG) that measures levels of RNA editing using the accumulation of the fluorescent proteins GFP and RFP²⁶. This system bears both the RFP and GFP ORFs in a single transcript, with a stop codon between them (Fig. 1A). So, cells bearing such reporter express RFP constitutively, but GFP is only produced if an RNA editing event changes the A of the stop codon to an I (Fig. 1A)²⁶. Therefore, the number of red cells that are also green indicates the efficiency of RNA editing. As a control to discard other effects non-related to the editing on this system, we used the RNWG control reporter, in which the stop codon is pre-edited, so all cells bearing the construct fluoresce, indeed, in red and green²⁶. In U2OS cells stably transfected with the reporter, we observed that DNA damage induced by ionizing radiation increased GFP expression by 50% specifically in the RNAG reporter and not in the RNWG control, in agreement with a DNA damage stimulation of RNA A-to-I editing in this system (Fig. 1B). Similar results were obtained when using the DNA damage-inducing drug camptothecin (Fig. 1C), where we could observe a dose-dependent effect on RNA editing stimulation. One possibility is that DNA damage induces the accumulation of the A-to-I editing machinery, namely ADAR1 and ADAR2 enzymes, thus increasing this process. However, neither of these proteins was upregulated, but were slightly downregulated, upon exposure to IR (Supplementary Fig. 1A). Then, in order to confirm this was a canonical induction of RNA editing, we depleted the A-to-I editing machinery. To choose which member of the ADAR family to downregulate, we revisited the data we obtained in a previous genome-wide screening for factors that unbalance the choice between DSB repair pathways²⁷. Interestingly, both ADAR1 and ADAR2, but not the catalytically inactive ADAR3, skewed DSB repair towards end-joining (Supplementary Figure 1B), and this was not due to changes in the cell cycle (Supplementary Fig. 1C). However, the effect was more prominent and clearer upon ADAR2 depletion. Indeed, downregulation of ADAR2 severely compromised both the basal and the DNA damage-induced expression of the GFP in the RNAG (Fig. 1D; for ADAR2 depletion efficiency see Supplementary Fig. 2A), but, as expected, not in the RNWG control reporter (Supplementary Fig. 2B).

**Fig. 1: DNA damage increases RNA editing.**

To better understand this phenomenon, we decided to look for DDR factors that affected the DNA damage-induced RNA editing. Recently, we have found that CtIP, a core DNA end resection factor that is also required for ATR activation, plays additional roles in DNA damage-induced RNA splicing²⁸. Interestingly, we could see that CtIP downregulation specifically eliminated the DNA damage-dependent induction of RNA editing without affecting the basal levels (Fig. 1D). Again, CtIP depletion did not alter GFP levels in the control RNWG system (Supplementary Fig. 2B). We could also complement this effect with the expression of siRNA-resistant flag-tagged CtIP in CtIP depleted cells, to the same extent as the control cells transfected with a non-targeting siRNA, even though overexpression of FLAG-CtIP on its own reduced the intensity of this DNA damage-induced phenotype (Supplementary Fig. 2C).

The general response to DNA damage is mainly controlled by the activation of two related apical kinases, ATM and ATR¹. Thus, we also tested if any of them was required for the induction of RNA editing upon irradiation. Interestingly, ATM inhibition did not affect DNA damage-induced RNA editing, while ATR inhibition decreased the DNA damage-induced editing increase (Fig. 1E). This agrees with the notion that ATR and CtIP act on the same branch of the DNA damage checkpoint in response to DSBs²⁹. The lack of response with the ATM inhibitor could be explained by a compensation by another member of the PIKK family, most likely DNA-PK. Along those lines, the ATR effect could also be affected by this phenomenon. Thus, we repeated the experiment with ATM, ATR, and DNA-PK inhibitors in different combinations (Fig. 1F). As shown, inhibition of ATR suppressed the DNA damage-induction of RNA editing, regardless of the presence of the inhibitors of ATM or DNA-PK. Interestingly, chemical inhibition of DNA-PK showed a limited increase in the basal levels of RNA editing, but importantly the exposure to DNA damage still provoked a hyperactivation of the process. Notably, concomitant inhibition of both DNA-PK and ATM abolished the induction of RNA editing caused by irradiation. Thus, it seems that those two kinases could have an overlapping role in this phenomenon.

ADAR2 depletion causes genomic instability and DNA damage sensitivity

To understand the consequences of reduced A-to-I RNA editing for genomic stability, we decided to globally reduce such RNA modifications. Based on our previous data with ADAR2 (Fig. 1D and Supplementary Fig. 1B), we decided to use the downregulation of this protein as a tool to reduce A-to-I RNA editing. Strikingly, and in agreement with a role in maintaining genomic stability, the depletion of ADAR2 impaired DSB repair, measured as the presence of γH2AX foci 24 h after irradiation. Spontaneous DNA damage accumulated in the absence of any exogenous genotoxic agent in ADAR2-depleted cells (Fig. 2A). Confirming a DSB repair impairment, the disappearance of γH2AX foci upon exposure to ionizing radiation was delayed (Fig. 2B). Indeed, repair levels of DSBs at 6 and 24 h after irradiation in ADAR2-depleted cells were similar to those observed after downregulation of the critical repair factor CtIP (Fig. 2B). Interestingly, and in agreement with an increased burden of spontaneous DNA damage, in the absence of ADAR2, we observed a significant increase of BRCA1 foci in cells unchallenged with any genotoxic agent (Fig. 2C). A similar effect was observed upon ADAR1 downregulation (Fig. 2D). Furthermore, micronuclei accumulated at high levels in ADAR2-depleted cells, regardless of the exposure to an external source of DNA damage (Fig. 2E). Finally, and confirming the role of ADAR2 in DNA repair and the maintenance of genomic stability, its depletion rendered cells hypersensitive to DSBs-inducing agents such as ionizing radiation or camptothecin (Fig. 2F, G).

**Fig. 2: ADAR2 depletion causes genetic instability and DNA repair defects.**

ADAR2 depletion affects DNA repair pathway choice

Next, we decided to test a possible requirement of A-to-I RNA editing for DSB repair. As mentioned, ADAR2 depletion skewed the balance between HR and NHEJ towards the latter (see ref. ²⁷and Supplementary Fig. 1B), suggesting that recombination might be compromised. Indeed, both RAD51-dependent gene conversion (GC) and RAD51-independent Single Strand Annealing (SSA), two types of homology-dependent repair (HDR), were reduced in cells downregulated for ADAR2 (Fig. 3A, B). In stark contrast, there was no impact on NHEJ efficiency (Fig. 3C), arguing that ADAR2 was particularly required for HR. The cell cycle is a major regulator of DSB repair pathway choice, as HR is limited in G1. However, the observed HR defect was not caused by an accumulation of G1 cells (Supplementary Fig. 1C). Thus, we conclude that ADAR2 facilitates repair by HR.

**Fig. 3: ADAR2 depletion affects homologous recombination.**

DNA resection requires ADAR2 editing activity

Due to its effect in recombination, we hypothesized that ADAR2 might have a role in the common, early steps of the homology-dependent repair pathways, namely in DNA end resection. To test this idea, we first studied RPA foci formation upon ionizing radiation in ADAR2-depleted cells. RPA is an ssDNA binding complex that accumulates at DNA breaks as a direct consequence of DNA end resection^4,5,30. Thus, the percentage of RPA foci-positive cells is the standard readout of resection in mammalian cells. Depletion of ADAR2 in U2OS cells caused a significant defect in resection, though less pronounced than that observed with the downregulation of the key resection factor CtIP (Fig. 4A and Supplementary Fig. 3A). For representative images of the experiment see Supplementary Fig. 3A. The same resection impairment was also observed upon depletion of ADAR2 in the HeLa cells (Supplementary Fig. 3B). Strikingly, similar results were observed upon depletion of ADAR1, but not the catalytically dead member of the ADAR family, ADAR3, thus suggesting that active RNA editing is required for DNA end resection (Fig. 4A and Supplementary Fig. 3A).

**Fig. 4: ADAR depletion impairs in DNA resection.**

To confirm that the observed phenotype in DNA resection was truly due to the reduction of ADAR2 levels and not to an indirect off-target effect, we studied RPA foci formation in cells bearing siRNA-resistant, GFP-tagged variants of ADAR2. Indeed, the resection impairment caused by depletion of ADAR2 was rescued by wild-type GFP-ADAR2 (Fig. 4B and Supplementary Fig. 3C). Importantly, this rescue was not observed with the expression of a catalytically dead version of the protein (GFP-ADAR2E-A) (Fig. 4B), arguing that ADAR2 deaminase activity was required for processive resection. Moreover, we could reproduce the resection defect in U118 cells³¹, a glioblastoma cell line that is defective for ADAR2 expression, when compared with the same cells complemented with a wild-type copy of the gene, but not a catalytically dead mutant (Fig. 4C).

To validate these observations, we analyzed recruitment of RPA to DSBs by other means. U2OS cells depleted for ADAR2, or CtIP as a control, were laser micro-irradiated and immunostained with antibodies against RPA and γH2AX to identify the irradiated areas. The percentage of γH2AX-positive stripes that were co-stained by RPA was determined (Fig. 4D). In agreement with our previous results, depletion of ADAR2, or CtIP, significantly diminished the presence of RPA at the irradiated areas. Finally, in order to analyze in more detail the resection defect related to ADAR2 depletion and to investigate whether only resection initiation was impaired or if resection processivity was also compromised, we used SMART, a high-resolution technique that measures resection in individual DNA fibres^32,33. As seen in Fig. 4E, the length of ssDNA fibres formed during the resection process was reduced upon ADAR2 depletion. Again, similar results were observed upon ADAR1 downregulation (Supplementary Fig. 3D), reinforcing the connection between A-to-I editing and DNA end resection.

Altogether, these results confirm that RNA editing by ADAR proteins facilitates DNA end resection at DSBs.

The role of ADAR2 on resection does not rely on the recoding of mRNAs that encode resection factors

Next, we wondered how this RNA editing activity might be needed for DNA end processing. We studied the recruitment DSB repair factors, such as 53BP1, BRCA1, and CtIP, to DNA damage foci shortly after DNA damage induction upon ADAR2 depletion. Notably, neither of them was affected in cells exposed to ionizing radiation or laser micro-irradiation (Supplementary Fig. 4A–C). Then, we wondered if ADAR2 was specifically editing mRNAs that code for resection factors. To analyze this possibility, we exposed the ADAR2-defective cell line U118 to ionizing radiation or mock treatment, isolated total RNA, and sequenced it. U118 cells complemented with either wild-type ADAR2 or a catalytically dead mutant were also processed in parallel. The levels of ADAR2 mRNA in the different samples are shown in Supplementary Fig. 4D. As expected, U118 cells complemented with wild-type ADAR2 showed a higher efficiency in editing the coding codons of known ADAR2 targets, expressed as the weighted average over all known recoding sites, known as the REI³⁴. Instead, non-complemented U118 cells showed little recoding editing, regardless of whether or not exposed to ionizing radiation (Fig. 4F). Equally expected, the expression of a catalytically dead enzyme also showed almost no recoding of mRNAs (Fig. 4F), despite the fact that such variant was expressed almost 3 times more than the wild-type ADAR2 (Supplementary Fig. 4D). Thus, only the expression of catalytically active enzyme led to the expected ADAR2-dependent recoding due to editing of specific codons (Fig. 4F). Interestingly, although some specific coding codons were edited more efficiently upon irradiation than in mock-treated cells, we observed a general decrease in the recoding editing efficiency of known ADAR2 substrates upon exposure to DNA damage (Fig. 4F and Supplementary Data 1). Moreover, we could not observe any change in the editing of mRNA from genes that code for recombination or resection factors either in cells exposed to DNA damage or in undamaged cells (Supplementary Table S1). Thus, we conclude that the role of ADAR2 in resection and recombination does not rely on changes in the sequence or expression of specific mRNAs of bona fide DNA repair factors. To integrate our data, in which we observed a general ADAR2-mediated increase in RNA editing in the reporter (Fig. 1) accompanied by a general reduction of its activity on known targets (Fig. 4F), we hypothesized that upon DNA damage ADAR2 is mobilized to induce RNA editing at new sites. Such re-distribution could mean that at least a fraction of the protein would localize at sites of DNA-DSBs. To test this idea, we analyzed the presence of GFP-tagged ADAR2 at damaged chromatin at different time points by laser micro-irradiation (Fig. 4G). In agreement with our idea, a fraction of GFP-ADAR2 was readily recruited to sites of DNA damage as early as 5 minutes after laser micro-irradiation, something not observed in cells expressing only GFP as a control. In fact, 50% of cells showed colocalization between γH2AX and ADAR2 stripes. Interestingly, such recruitment seemed transient, as it was no longer observed 30 min after irradiation. This recruitment pattern agrees with the idea that ADAR2, or at least a fraction of the protein, changes its substrates and is channeled towards RNAs at the sites of broken chromatin to play a role in the early steps of DSB repair.

ADAR2 facilitates resection over DNA:RNA hybrids

We hypothesized that the ADAR2-depletion related phenotype in DNA resection could be caused by a direct effect of ADAR2 on an RNA molecule located in the vicinity of the break that would act as a physical barrier for DNA end processing. The presence of DNA:RNA hybrids close to DSBs has been documented from yeast to mammals, both as pre-existing R-loops, R-loops formed as a consequence of breaks in transcribed regions or as DNA:RNA hybrids resulting from de novo transcription of resected DNA ends^{9,13,16,35,36,37}. The actual effect of such DNA:RNA hybrids in resection is controversial, with both pro- and anti-resection effects described^9,16,38. Importantly, ADAR2 has been proposed to recognize and edit DNA:RNA hybrids in vitro³⁹. In order to define whether ADAR2 involvement in DNA end resection depended on the presence of DNA:RNA hybrids, we repeated the resection assay in the presence or absence of ectopically overexpressed RNaseH1, an enzyme that degrades the RNA moiety of such structures⁴⁰. ADAR2 depletion and RNaseH1 overexpression efficiency are documented in Supplementary Fig. 5A. Strikingly, the overexpression of RNaseH1 in U2OS reverted ADAR2 resection phenotype as measured by RPA foci accumulation (Fig. 5A and Supplementary Fig. 5B). Indeed, the mere overexpression of RNaseH1 facilitated RPA foci formation even in cells transfected with a control siRNA, arguing that DNA:RNA hybrids act generally as physical barriers for the resection process, and that ADAR2 helps overcome such roadblocks. To confirm this finding, we studied the recruitment of RPA to damaged chromatin in HeLa cells depleted of ADAR2 and overexpressing RNaseH1. Again, such overexpression rescued the resection phenotype of ADAR2 depletion (Fig. 5B). The same was observed, albeit only partially, when laser micro-irradiation experiments were performed (Fig. 5C). In none of those cases, the increase in RPA-positive cells was due to changes in cell cycle profile when the RNaseH1 was overexpressed (Supplementary Fig. 5C). Then, to assess whether ADAR2 helped remove DNA:RNA hybrids, we analyzed the accumulation of such structures by immunofluorescence using the DNA:RNA hybrid-specific antibody S9.6⁴¹. As shown in Fig. 5D, depletion of ADAR2 increases the nuclear signal with that antibody. To rule out the contribution of other nucleic acid structures to the increase in the S9.6 signal, we overexpressed RNaseH1 and observed a significant reduction in the staining (Fig. 5D). Of relevance, ADAR2 has been previously found to be a part of the so-called “DNA:RNA hybrid interactome”⁴². Therefore, we decided to test if ADAR2 could interact directly with DNA:RNA hybrids. Indeed, ADAR2 was specifically immunoprecipitated using the S9.6 antibody, in a similar fashion as Senataxin (SETX), a helicase described to dissolve such hybrids and that has been shown to be recruited to DSBs at transcribed regions¹³ (Fig. 5E). This immunoprecipitation was specific, as did not occur when a control antibody was used (Fig. 5E).

**Fig. 5: The connection of DNA resection defect with R-loop increase.**

Taken together, our results suggest the ADAR2 effect in resection was caused by DNA:RNA hybrid accumulation. A prediction of this model is that the decrease in HR caused by ADAR2 downregulation should be suppressed by RNaseH1 overexpression. In fact, recombination was almost completely restored in ADAR2-depleted cells when such enzyme was ectopically expressed (Fig. 5F). Such effect was not due to a general increase of recombination mediated by RNaseH1 overexpression, as it was not observed either in CtIP depleted or control cells.

Increase of DNA:RNA hybrids generally impairs DNA end resection

Due to our observation that DNA:RNA hybrids hampered resection in the absence of ADAR proteins, we wondered if other enzymes involved in the removal of hybrids also affected DNA end resection, therefore this represented a more general phenomenon. We decided to test SETX, due to its aforementioned relationship with DSBs. So, we checked if its loss also affected RPA foci formation. Indeed, depletion of Senataxin also produced a DNA resection defect measured by RPA foci accumulation (Fig. 6A) and reduced the length of resected DNA (Fig. 6B). As seen for ADAR2 depletion, SETX downregulation also led to an increased burden of spontaneous DNA damage, measured as BRCA1 foci in unchallenged cells (Fig. 6C).

**Fig. 6: DNA:RNA hybrid stabilization impairs resection.**

ADAR proteins physically interact with Senataxin and BRCA1

Our data suggested a possible role of ADAR2 in R-loop resolution, which would be key for facilitating DNA end resection and HR. Hence, we wondered if ADAR2 might interact with known players in the homeostasis of R-loops that are also connected with DSB repair. Many different enzymes have been associated with the removal of R-loops. Among them, we decided to focus on the BRCA1–SETX complex. These two proteins have been shown to cooperate in the elimination of R-loops in the 3' end of many transcribed genes⁴³. Moreover, both proteins play roles in DNA end resection, as it has been previously established for BRCA1³³ and in this study for Senataxin (Fig. 6A–C). Thus, we tested whether ADAR proteins might physically interact with BRCA1 and Senataxin. Using antibodies against BRCA1, we confirmed the previously shown interaction of this protein with Senataxin⁴³ and also established an interaction with ADAR1 and ADAR2 (Fig. 6D). An additional, independent co-immunoprecipitation experiment between ADAR2 and BRCA1 can be found in Supplementary Fig. 6A. These interactions were not stimulated by the presence of DNA damage, at least measured 1 h after irradiation (Fig. 6D). Also, by co-immunoprecipitations with different antibodies we could observe the reciprocal interaction of ADAR proteins with both BRCA1 and SETX (Fig. 6E–F). The possibility that ADAR immunoprecipitation could be bringing down any proteins accumulating at sites of DNA DSBs was excluded, since we could not observe an interaction of ADAR2 with the DNA-end binding protein Ku80, suggesting that those interactions were, indeed, specific. It is worth pointing out that these co-immunoprecipitations were performed in the presence of benzonase, thus they are not bridged by DNA. Moreover, immunoprecipitation using an antibody against SETX also allows the co-precipitation of ADAR2 (Fig. 6G). Additional, independent co-immunoprecipitation experiments between ADAR1, ADAR2, and SETX can be found in Supplementary Fig. 6B. Therefore, we could confirm that these proteins interact in a DNA damage-independent fashion, most likely to facilitate the removal of DNA:RNA hybrids globally.

Discussion

mRNA post-transcriptional modifications are now being revealed as potent regulators of cellular metabolism that allow flexibility and adaptability to a changing environment⁴⁴. Such chemical modifications of the mRNA can recode coding sequences, create or destroy splicing sites, affect RNA stability and structure, or directly interact with specific readers in order to recruit specific machinery affecting translation and/or mRNA localization. Therefore, those modifications affect virtually every aspect of the biological response of the cells. In fact, it has been recently shown that other base modifications of RNA happen at DNA:RNA hybrids and contribute to genomic stability⁴⁵. Thus, it was reasonable to expect that A-to-I RNA editing would contribute to the global response to DNA damage. Indeed, our results support this notion, uncovering a bona fide role of A-to-I deamination by ADAR1 and ADAR2 in the maintenance of genomic integrity upon exposure to genotoxic agents. ADAR2-mediated RNA editing seems, indeed, completely upturned upon treatment with DNA damaging agents. Many of the codons in mRNAs that are usually targeted by ADAR2 decrease their editing, whereas specific codons on natural mRNAs and in other RNA species such as the RNAG reporter increase their editing. Based on these findings, we propose an RNA-editing DDR (REDAR) that is essential for DNA repair, and specifically for HR, contributing to the maintenance of genomic integrity.

Specifically, we postulate that upon the triggering of the DDR, REDAR is activated by ATR and CtIP. Then, ADAR2, and maybe ADAR1, is mobilized from its usual targets to new ones, most likely including DNA:RNA hybrids, in order to help with their dissolution. In this regard, ADAR2 action might have two non-mutually-exclusive outcomes; on the one hand, it can rapidly and transiently relocate to promote RNA editing at the sites of DSBs, aiding in the removal of DNA:RNA hybrids and facilitating DNA end resection; and on the other hand, it can increase the editing of a small fraction of yet-undisclosed mRNAs, whose role in the DDR should be clarified in further studies. Interestingly, it has been previously shown that ADAR action can alter the biochemical properties of some DNA repair enzymes²³. We envision that the transcriptional inhibition induced by the DDR^46,47 will cause a reduction of the normal co-transcriptional RNA editing⁴⁸ and will free ADAR to act on alternative substrates such as the aforementioned DNA:RNA hybrids. We favor the idea that the editing itself would happen on the RNA moiety of the structure. However, by performing an in silico study we observed that cancer cells that overexpress ADAR2 are statistically more likely to accumulate this kind of mutations (Supplementary Fig. 7). Thus, it is also possible that the editing occurs in the DNA strand, as suggested in vitro³⁹, albeit how frequently and whether this happens in the context of DNA repair is still unclear. Editing of the DNA strand would greatly increase the mutagenesis associated with HR, something that might be deleterious for the cells, but has been observed due to the action of C-to-U deaminases in cancer⁴⁹. Interestingly, the accumulation of N6-methyladenosine modification on the RNA at DNA:RNA hybrids has also been shown to ease the dissolution of such structures⁴⁵. As A-to-I editing is negatively influenced by m⁶A modifications^50,51, the crosstalk between those two RNA post-transcriptional modifications during DNA repair and in response to DNA damage will be worth exploring further.

The mechanism by which ADAR2 is relocated in response to DNA damage is still far from clear. On the one hand, a passive model is possible, in which ADAR2 naturally recognizes and binds to DNA:RNA hybrids. It has been shown that DNA damage induces the formation of such structures and, in this scenario, the accumulation of hybrids would sequester ADAR2, reducing its availability to edit its usual targets. Indeed, using GFP-tagged versions of ADAR2 we could observe a re-localization to laser micro-irradiated stripes. However, such accumulation is very transient, and in a completely different timeframe of the changes in recoding we have also shown. So, this recruitment cannot fully explain the changes in editing we observed globally, arguing for the coexistence of both a global, genome-wide effect, and a site-specific role. It is even possible that, in this context, during REDAR, ADAR2 would not act specifically at DNA:RNA hybrids that are close to DSBs, but rather relocated to hybrids spread through the genome as a broad response to DNA damage. In this scenario, the accumulation at laser lines we observed would rely simply on the already known accumulation of hybrids at break sites. Indeed, the SETX–BRCA1 complex has been proposed to be important and recruited mainly to transcription termination sites, regardless of the presence of DNA damage⁴³, thus again arguing with for putative role that does not require specific recruitment to DSBs. Alternatively, there could be an active, recruitment of ADAR2 to hybrids that sit specifically in the proximity of DSBs. The physical interaction with BRCA1, a well-established, bona fide member of the DDR, which is recruited to DSBs⁵² and Senataxin, that is also localized to damaged chromatin¹³, might favor this model. This idea is also supported by the fact that A-to-I editing at new sites is upregulated upon REDAR activation in an ATR-dependent manner, arguing for a DNA damage-dependent recruitment of ADAR2 to those new target sites. Interestingly, the ATR checkpoint is mainly active in S and G2, as it requires ssDNA for its activation that is produced by DNA end resection. This would explain why CtIP downregulation also decreases the DNA damage-induced increase of RNA editing in the RNAG system, simply reflecting the role of CtIP in the ATR activation upon formation of DSBs.

CtIP is linked to RNA metabolism in multiple ways. It affects RNA editing, as shown here, but also interacts with multiple RNA binding proteins⁵³ that in turn are required for proper resection. Moreover, we have recently shown that CtIP controls the splicing of specific factors, in many cases facilitating the accumulation of specific alternative splicing forms upon exposure to DNA damage⁵⁴. Additionally, CtIP not only interacts with BRCA1, which also affects RNA splicing, but also CtIP deficiency has been shown to promote the accumulation of DNA:RNA hybrids at sites of highly expressed genes¹⁴. Paradoxically, CtIP depletion reduces DNA:RNA hybrid accumulation dependent on de novo transcription of dilncRNA (damage-induced long non-coding RNAs) starting at DSBs³⁶. Hence, CtIP depletion seems to increase R-loops that are produced as a consequence of the previous transcription and appears to decrease de novo production of diRNAs (DSB-induced small RNA), thus reducing the DNA:RNA hybrids formed after DNA damage. The data suggest that DNA resection, and specifically CtIP and BRCA1, are in close relationship with the general metabolism of RNAs, a reciprocal connection that is worth to continue exploring.

To integrate all our observations, we present a model in which ADAR2 (and most likely ADAR1), BRCA1, and SETX facilitate the removal of hybrids genome-wide even in the absence of DNA damage, but in a way that is stimulated by the DDR during REDAR. When exposed to a source of DSBs, the levels of DNA:RNA hybrids and R-loops increase, as previously described by other authors^13,14,15,16, and many of them specifically accumulate at break sites. Although some authors argue that these structures might favor the repair process³⁸, others favor a view in which they act as roadblocks for repair (for a review see ref. ³⁷). This contradiction might simply stem from a differential effect of DNA:RNA hybrids depending on the timing of repair, i.e. very early events might need them but later they have to be eliminated, or the position of the hybrids, as discussed elsewhere^9,55. Our data agree with the notion that at least some of them represent roadblocks for the progression of the repair machinery that has to be removed prior to repair (Fig. 6G-1). Such blocking effect of R-loops is well established for other DNA transactions such as transcription and replication^37,56. We propose that, upon irradiation, a CtIP- and ATR-mediated global induction of A-to-I editing at DNA:RNA hybrids facilitate their removal both genome-wide and locally, at sites of DNA breaks, hence permitting the DNA end resection machinery to overcome the physical barrier represented by pre-existing or recently formed hybrids close to the DNA breaks (Fig. 6G–2). Mechanistically, we suggest that ADAR-mediated editing of DNA:RNA hybrids, an activity that has been confirmed in vitro^39,57, might alter the sequence of the RNA strand creating ribo–inosine (rI) and the deoxiribose–thymine (dT) mismatches (Fig. 6G–3). The appearance of those mismatches will loosen up the interaction between the RNA and the DNA strand, facilitating the unwinding of the structure by the helicase activity of SETX (Fig. 6G–3,4), allowing the resection machinery to go through (Fig. 6G–4,5). Strikingly, ADAR proteins were first discovered in Xenopus as having developmentally regulated dsRNA unwinding activity in oocytes⁵⁸, and later shown to rely on the modification of A–to–I in the RNA substrate, which modified the base-pairing properties and facilitated the melting of that RNA:RNA double-stranded structures⁵⁹. Alternatively, rather than physically loosening the interaction between the DNA and RNA, A-to-I modification of the RNA might help the recruitment of proteins involved in R-loop removal or even the recruitment of bona fide resection factors. We propose that this alteration of the RNA moiety of the hybrids will happen at all R-loops scattered across the genome, even in the absence of DNA damage. But particularly at DSBs, ADAR2 will contribute to the processivity of resection over DNA:RNA hybrids, regardless of if these structures preceded or formed as a consequence of the break in its vicinity. Our model proposes a role of ADAR in DNA end resection and recombination that acts independently but not exclusively, of the recoding or regulation of expression of yet-undisclosed mRNAs. Interestingly, recently it has been shown that ADAR1 editing activity is required to eliminate R-loops at telomeric repeats in order to preserve genomic integrity⁵⁷. In this case, ADAR1 has been proposed to edit mismatched hybrids formed by TERRAs and non-canonical telomeric repeats in order to facilitate its removal by RNaseH2, a phenomenon that is specific in non-ALT cancer cell lines. Thus, albeit with slightly different mechanisms, this confirms that RNA editing affects genomic integrity by regulating DNA:RNA hybrid elimination.

Strikingly, ADAR deficiency, and generally unbalance the levels of editing of the RNA, have been associated with the development of many different tumors^24,25,34,60. Specific editing events have already been associated with glioblastoma^22,61. However, in the light of this new role for ADAR2 in DNA repair and the DDR, it might be important to extend the connection of this protein with cancer and establish if it is linked to a particular genomic instability signature.

Methods

Cell lines and growth conditions

All cell lines were grown in DMEM (Sigma-Aldrich) supplemented with 10% fetal bovine serum (Sigma-Aldrich), 2 mM L-glutamine (Sigma-Aldrich), 100 units ml⁻¹ penicillin, and 100 μg ml⁻¹ streptomycin (Sigma-Aldrich). U2OS and U118-derived cell lines stably expressing GFP or GFP–ADAR2 plasmids³¹ were grown in a standard medium supplemented with 0.5 mg ml⁻¹ G418 (Gibco, Invitrogen). Cells expressing RNWG and RNAG were grown in standard medium supplemented with 0.5 mg ml⁻¹ G418 (Gibco, Invitrogen).

siRNAs, plasmids and transfections

siRNA duplexes were obtained from Sigma-Aldrich or Dharmacon (Supplementary Table 1) and were transfected using RNAiMax Lipofectamine Reagent Mix (Life Technologies), according to the manufacturer’s instructions. RNWG and RNAG was a gift from Dr. Jantsch’s lab²⁶. The GFP-ADAR2 and GFP-ADAR2 mutant (GFP-ADAR2-E/A-) plasmids were previously described³¹. RNaseH1 overexpression was achieved with the pCDNA3–RNAseH1 vector⁶² and pCDNA3 (Invitrogen) was used as a control. Plasmid transfection of U2OS cells was carried out using FuGENE 6 Transfection Reagent (Promega) according to the manufacturer’s protocol, with the exception of pCDNA3–RNaseH1 and pCDNA3 plasmids that were transfected using Lipofectamine 3000 (Invitrogen) according to the manufacturer’s instructions.

HR and NHEJ analysis

U2OS cells bearing a single copy integration of the reporters DR-GFP (Gene conversion)⁶³, SA-GFP (SSA)⁶⁴, or EJ5-GFP (NHEJ)⁶⁴ were used to analyze the different DSB repair pathways. In all cases, 50,000 cells were plated in 6-well plates in duplicate. One day after seeding, cells were transfected with the indicated siRNA and the medium was replaced with a fresh one 24 h later. The next day, each duplicate culture was infected with lentiviral particles containing I-SceI–BFP expression construct at MOI 10 using 8 µg/ml polybrene in 1.5 ml of DMEM. Then, cells were left to grow for an additional 24 h before changing the medium for fresh DMEM, 48 h after siRNA transfection, cells were washed with PBS, trypsinized, neutralized with DMEM, centrifuged for 5 min at 700 g, fixed with 4% paraformaldehyde for 20 min, and collected by centrifugation. Then, cell pellets were washed once with PBS before resuspension in 150 µl of PBS. Samples were analyzed with a BD FACSAria with the BD FACSDiva Software v5.0.3. Four different parameters were considered: side scatter (SSC), forward scatter (FSC), blue fluorescence (407 nm violet laser BP, Filter 450/40), green fluorescence (488 nm blue laser BP Filter 530/30). Finally, the number of green cells from at least 10,000 events positives for blue fluorescence (infected with the I-SceI–BFP construct) was scored. The average of both duplicates was calculated for each sample of every experiment. To facilitate the comparison between experiments, this ratio was normalized with siRNA control. At least four completely independent experiments were carried out for each condition and the average and standard deviation are represented.

RNA editing assay in vivo

The cells were seeded in 60 mm plates and transfected with siRNAs 24 h later. The cells were irradiated with 10 Gy or treated with the indicated doses of CPT and incubated during 12 h before harvesting. In the experiments performed with protein inhibitors, the medium was exchanged 2 h before irradiation with fresh DMEM containing 10 μM ATMi (KU55933), 5 μM ATRi (ETP46464), 10 μM DNA–PKi (NU7441), or DMSO as control. After that, the medium was replaced, DSBs were induced with the indicated DNA damage agent, and cells were incubated for 10 h. Then, cells were harvested with trypsin, spun down at 500 g for 5 min and washed with PBS. The cells were fixed with 4% paraformaldehyde for 15 min at 4 °C in the dark and later rinsed and resuspended in 150 μl of PBS. Red and green fluorescence was measured on BD FACSAriaTM using FACSDiva v5.0.3 software as indicated in the above section.

Clonogenic cell survival assays

To study cell survival after DNA damage, clonogenic assays were carried out seeding cells in 6-well plates at two different concentrations in triplicates. DSBs were produced by IR or by acute treatment with topoisomerase inhibitor camptothecin (CPT; Sigma). For IR, 250 and 500 transfected cells were seeded per well and, for drug treatments, 500 and 1,000 cells per well. The following day, cells were exposed to DNA damaging agents: 2 Gy, 4 Gy or mock treated or incubated for 1 h with 0.01, 0.05, or 0.1 μM CPT or vehicle (DMSO) as control. After two washes with PBS, a fresh medium was added and cells were incubated at 37 °C for 7–14 days to allow colony formation. Afterward, cells were stained and visualized in the solution of 0.5% Crystal Violet (Merck) and 20% ethanol (Merck). Once the colonies were stained, this solution was removed and plates were washed with water. The surviving percentage at each dose was calculated by dividing the average number of visible colonies in treated versus control (untreated or vehicle-treated) dishes.

SDS-PAGE and western blot analysis

Protein extracts were prepared in 2× Laemmli buffer (4% SDS, 20% glycerol, 125 mM Tris–HCl, pH 6.8) and passed ten times through a 0.5 mm needle–mounted syringe to reduce viscosity. Proteins were resolved by SDS–PAGE and transferred to low fluorescence PVDF membranes (Immobilon-FL, Millipore). Membranes were blocked with Odyssey Blocking Buffer (LI-COR) and blotted with the appropriate primary antibody and infrared dyed secondary antibodies (LI-COR) (Supplementary Tables 2, 3). Antibodies were prepared in blocking buffer supplemented with 0.1% Tween-20. Membranes were air-dried in the dark and scanned in an Odyssey Infrared Imaging System (LI-COR), and images were analyzed with Image Studio software (LI-COR).

Immunoprecipitation

U2OS cells or U2OS cells containing GFP or GFP-CtIP were harvested in lysis buffer (50 mM Tris–HCl, pH 7.4, 100 mM NaCl, 1 mM EDTA, 0.2 % Triton X-100, 1X protease inhibitors (Roche), 1X phosphatase inhibitor cocktail 1 (Sigma)) and incubated for 30 min on ice with Benzonase (90 U/ml), with the exception of the S9.6 IP in which samples were sonicated for 15 min. Protein extract (1 mg) was incubated at 4 °C with 10 μl of anti-BRCA1, anti-SETX, anti-ADAR2, or S9.6 antibody (Supplementary Table 2) or with an equivalent amount of IgG (Mouse or Rabbit) as the negative control. Afterward, extracts were incubated with magnetic protein A Dynabeads (Novex) overnight. Beads were then washed three times with lysis buffer, and the precipitate was eluted in 50 μl of Laemmli buffer 2x.

Immunofluorescence and microscopy

For RPA, γH2AX, and BRCA1 foci visualization, U2OS cells knocked down for different proteins were seeded on coverslips. The cells were treated with 10 Gy ionizing irradiation and incubated for 1 h. Then, coverslips were washed once with PBS followed by treatment with Pre extraction Buffer (25 mM Tris–HCl, pH 7.5, 50 mM NaCl, 1 mM EDTA, 3 mM MgCl₂, 300 mM sucrose, and 0.2% Triton X-100) for 5 min on ice. Cells were fixed with 4% paraformaldehyde (w/v) in PBS for 20 min. For 53BP1 foci, cells growing on coverslips were treated for 10 min on ice with methanol and 30 s with acetone. In all cases, following two washes with PBS, cells were blocked for 1 h with 5% FBS in PBS, co-stained with the appropriate primary antibodies (Supplementary Table 2) in blocking solution overnight at 4 °C or for 2 h at room temperature, washed again with PBS and then co-immunostained with the appropriate secondary antibodies (Supplementary Table 3) in blocking buffer. After washing with PBS and dried with ethanol 70% and 100% washes, coverslips were mounted into glass slides using Vectashield mounting medium with DAPI (Vector Laboratories). Images were acquired and analyzed using a Leica fluorescence microscope. The analysis of 53BP1 number foci formation was performed automatically using MetaMorph software.

SMART (Single-Molecule Analysis of Resection Tracks)

SMART was performed as described³². Briefly, cells were grown in the presence of 10 μM BrdU for <24 h. Cultures were then irradiated (10 Gy) and harvested after 1 h. Cells were embedded in low-melting agarose (Bio-Rad), followed by DNA extraction. DNA fibers were stretched on silanized coverslips, and immunofluorescence was carried out to detect BrdU (Supplementary Table 2, 3). Samples were observed under a Nikon NI-E microscope, and images were taken and processed with the NIS ELEMENTS Nikon Software. For each experiment, at least 200 DNA fibers were analyzed, and the length of the fibers was measured with Adobe Photoshop CS4.

Cell cycle analysis

Cells were fixed with cold 70% ethanol overnight, incubated with 250 μg ml⁻¹ RNase A (Sigma) and 10 μg ml⁻¹ propidium iodide (Fluka) at 37 °C for 30 min and analyzed with a FACSCalibur (BD). Cell cycle distribution data were further analyzed using ModFit LT 3.0 software (Verity Software House Inc).

UV laser micro-irradiation

Cells were micro-irradiated using a wide-field Angström’s microscope (Leica) equipped with a Micropoint pulsed dye laser of 365 nm (Photonic Instruments, Inc.). The cells were seeded in 25 mm coverslips and cultured overnight in the presence of 10 μM BrdU before laser micro-irradiation. About 40–50 cells were micro-irradiated with one laser stripe per cell. For RPA study, cells were pre-permeabilized with CSK Buffer (10 mM PIPES, 300 mM sucrose, 100 mM NaCl, 3 mM MgCl₂, 1 mM EGTA) for 10 min. Then, cells were fixed for 10 min with 3.6% formaldehyde, permeabilized with 0.1% Triton X-100 for 15 min, and blocked for 30 min with 5% bovine serum albumin (BSA) in phosphate-buffered saline (PBS). Antibodies (Supplementary Tables S3, S4) were diluted in 1% BSA in PBST (PBS containing 0.01% Tween-20) and incubated for 1 h. Coverslips were mounted using Vectashield mounting medium with DAPI (Vector Labs) and the slides were visualized in an LSM780 confocal microscope (Carl Zeiss) with an optical thickness of 0.9 μm. Quantitative analyses of the number of cells with foci or stripes were carried out in random areas using FIJI software. The number of stripes was quantified in 20–30 cells per preparation.

RNA isolation, RNA sequencing, and in silico analysis

RNA extracts were obtained from cells using the RNeasy Mini kit (QIAGEN, 74104) according to the manufacturer’s instructions. The RNA was purified with a standard phenol:chloroform extraction followed by ethanol precipitation.

RNA concentration was quantified by measuring 260 nm absorbance using a NanoDrop ND-1000 spectrophotometer, and the quality of the sample was checked by running a 1% agarose gel and by RNA 6000 Nano assay on a 2100 Bioanalyzer (Agilent Technologies).

RNA-Seq data (76 bp strand-oriented reads generated from Illumina platform) were first processed for adapters trimming and low-quality reads filtering. Then, cleaned reads were mapped against reference human genome (hg19), transcriptome and dpSNP by HISAT2 v.2.0.1⁶⁵, and only uniquely and concordantly mapped reads have been used for subsequent analyses. RNA editing analysis was performed using a specific Python tool, REDItools⁶⁶, with default parameters for the detection of the RNA editing sites collected in the REDIportal database⁶⁷. Recoding Editing Index was calculated as previously shown³⁴.

DNA:RNA hybrid detection

S9.6 (hybridoma cell line HB-8730) and RNaseH1 (15606-1-AP; Proteintech) immunofluorescence (IF) was performed 48 h after siRNA transfection. Cells were fixed with ice-cold methanol, blocked and subsequently incubated with the primary and secondary antibodies. Nuclei were stained with DAPI. The S9.6 signal in nucleoli was subtracted from the integrated nuclear S9.6 signal to perform the analysis. Immunofluorescence images were acquired using a Leica DM6000 wide-field microscope equipped with a DFC390 camera at x63 magnification using the LAS AF software (Leica). Microscopy data analysis was performed using the Metamorph v7.5.1.0 software (Molecular Probes).

ICGC data retrieval and analysis

Mutations sets were retrieved from the International Cancer Genome Consortium (ICGC) Data Portal MALY-DE and CLLE-ES datasets. ADAR2 expression levels from each donor were obtained using the UCSC Xena web tool. Open-access somatic mutations information from each mutation set was obtained by comparing each mutation set with the latest release of the Aggregated Somatic Mutation VCF file by the ICGC using custom python scripts. The percentage of A to G and T to C mutations was calculated as the quotient between the number of A to G mutations and T to C mutations to the total number of mutations from each donor set.

Statistical analysis

Unless specifically specified, statistical significance was determined with a Student’s t-test using PRISM software (Graphpad Software Inc.). Statistically significant differences were labeled with one, two, or three asterisks if p < 0.05, p < 0.01, or p < 0.001, respectively.

Reporting summary

Further information on research design is available in the Nature Research Reporting Summary linked to this article.

Data availability

The data supporting the findings of this study are available from the corresponding authors upon reasonable request. RNA-sequencing data have been deposited Sequence Read Archive (SRA) database and are accessible through the SRA accession number PRJNA747125. Source data for the figures and supplementary figures are provided as a Source data file. Source data are provided with this paper.

References

Jackson, S. P. & Bartek, J. The DNA-damage response in human biology and disease. Nature 461, 1071–1078 (2009).
Article ADS CAS PubMed PubMed Central Google Scholar
Davis, A. J. A. & Chen, D. D. J. DNA double strand break repair via non-homologous end-joining. Transl. Cancer Res. 2, 130–143 (2013).
CAS PubMed Google Scholar
Jasin, M. & Rothstein, R. Repair of strand breaks by homologous recombination. Cold Spring Harb. Perspect. Biol. 5, https://pubmed.ncbi.nlm.nih.gov/24097900 (2013).
Symington, L. S. et al. End Resection at Double-Strand Breaks: Mechanism and Regulation End Resection at Double-Strand Breaks: Mechanism and Regulation. https://doi.org/10.1101/cshperspect.a016436 (2014).
Cejka, P. DNA end resection: nucleases team up with the right partners to initiate homologous recombination. J. Biol. Chem. 290, 22931–22938 (2015).
Article CAS PubMed PubMed Central Google Scholar
Boucas, J. et al. Posttranscriptional regulation of gene expression-adding another layer of complexity to the DNA damage response. Front. Genet. 3, 159 (2012).
Article PubMed PubMed Central Google Scholar
Kai, M. Roles of RNA-binding proteins in DNA damage response. Int. J. Mol. Sci. 17, 1–9 (2016).
Article ADS Google Scholar
Naro, C., Bielli, P., Pagliarini, V. & Sette, C. The interplay between DNA damage response and RNA processing: The unexpected role of splicing factors as gatekeepers of genome stability. Front. Genet. 6, 1–10 (2015).
Article CAS Google Scholar
Jimeno, S., Prados-Carvajal, R. & Huertas, P. The role of RNA and RNA-related proteins in the regulation of DNA double strand break repair pathway choice. DNA Repair (Amst). https://doi.org/10.1016/j.dnarep.2019.102662 (2019).
Jungmichel, S. & Blasius, M. Rapid and transient protein acetylation changes in response to DNA damage. Cell Cycle 12, 1993–1994 (2013).
Article CAS PubMed PubMed Central Google Scholar
Matsuoka, S. et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 316, 1160–1166 (2007).
Article ADS CAS PubMed Google Scholar
Smolka, M. B., Albuquerque, C. P., Chen, S.-H. & Zhou, H. Proteome-wide identification of in vivo targets of DNA damage checkpoint kinases. Proc. Natl Acad. Sci. 104, 10364–10369 (2007).
Article ADS CAS PubMed PubMed Central Google Scholar
Cohen, S. et al. Senataxin resolves RNA:DNA hybrids forming at DNA double-strand breaks to prevent translocations. Nat. Commun. https://pubmed.ncbi.nlm.nih.gov/29416069/ (2018).
Makharashvili, N. et al. Sae2/CtIP prevents R-loop accumulation in eukaryotic cells. Elife 7, 1–33 (2018).
Article Google Scholar
Francia, S. et al. Site-specific DICER and DROSHA RNA products control the DNA-damage response. Nature 488, 231–235 (2012).
Article ADS CAS PubMed PubMed Central Google Scholar
Prim, J. D. et al. EXOSC10 is required for RPA assembly and controlled DNA end resection at DNA double-strand breaks. Nat. Commun. 10, 2135 (2019).
Article ADS CAS Google Scholar
Laurencikiene, J., Kallman, A. M., Fong, N., Bentley, D. L. & Ohman, M. RNA editing and alternative splicing: the importance of co-transcriptional coordination. EMBO Rep. 7, 303–307 (2006).
Article CAS PubMed PubMed Central Google Scholar
Gallo, A., Vukic, D., Michalík, D., O’Connell, M. A. & Keegan, L. P. ADAR RNA editing in human disease; more to it than meets the I. Hum. Genet. 136, 1265–1278 (2017).
Article CAS PubMed Google Scholar
Nishikura, K. A-to-I editing of coding and non-coding RNAs by ADARs. Nat. Rev. Mol. Cell Biol. 17, 83–96 (2016).
Article CAS PubMed Google Scholar
Maas, S. & Rich, A. Changing genetic information through RNA editing. Bioessays 22, 790–802 (2000).
Article CAS PubMed Google Scholar
Maas, S., Kawahara, Y., Tamburro, K. M. & Nishikura, K. A-to-I RNA editing and human disease. RNA Biol. 3, 1–9 (2006).
Article CAS PubMed Google Scholar
Cenci, C. et al. Down-regulation of RNA editing in pediatric astrocytomas: ADAR2 editing activity inhibits cell migration and proliferation. J. Biol. Chem. 283, 7251–7260 (2008).
Article CAS PubMed Google Scholar
Yeo, J., Goodman, R. A., Schirle, N. T., David, S. S. & Beal, P. A. RNA editing changes the lesion specificity for the DNA repair enzyme NEIL1. Proc. Natl Acad. Sci. U. S. A. 107, 20715–20719 (2010).
Article ADS CAS PubMed PubMed Central Google Scholar
Paz, N. et al. Altered adenosine-to-inosine RNA editing in human cancer. Genome Res. 17, 1586–1595 (2007).
Article CAS PubMed PubMed Central Google Scholar
Han, L. et al. The Genomic landscape and clinical relevance of A-to-I RNA editing in human cancers. Cancer Cell 28, 515–528 (2015).
Article CAS PubMed PubMed Central Google Scholar
Garncarz, W., Tariq, A., Handl, C., Pusch, O. & Jantsch, M. F. A high throughput screen to identify enhancers of ADAR-mediated RNA-editing. RNA Biol. 10, 192–204 (2013).
Article CAS PubMed PubMed Central Google Scholar
López-Saavedra, A. et al. A genome-wide screening uncovers the role of CCAR2 as an antagonist of DNA end resection. Nat. Commun. http://pubmed.ncbi.nlm.nih.gov/27503537 (2016).
Carvajal, R. P., Real, G. R., Gutierrez-Pozo, G. G. & Huertas, P. CtIP-mediated alternative mRNA splicing finetunes the DNA damage response. RNA 27, 303–323 (2021).
Article Google Scholar
Peterson, S. E. et al. Activation of DSB processing requires phosphorylation of CtIP by ATR. Mol. Cell 49, 657–667 (2013).
Article CAS PubMed Google Scholar
Huertas, P. DNA resection in eukaryotes: deciding how to fix the break. Nat. Struct. Mol. Biol. 17, 11–16 (2010).
Article CAS PubMed PubMed Central Google Scholar
Tomaselli, S. et al. Modulation of microRNA editing, expression and processing by ADAR2 deaminase in glioblastoma. Genome Biol. 16, 1–19 (2015).
Article CAS Google Scholar
Huertas, P. & Cruz-Garcia, A. Single molecule analysis of resection tracks.Genome Instability https://link.springer.com/book/10.1007/978-1-4939-7306-4 (2018).
García, A. C., Saavedra, A. L., & Huertas, P. BRCA1 accelerates CtIP-mediated DNA-end resection. Cell Rep. 9, 451–459 (2014).
Article CAS Google Scholar
Silvestris, D. A. et al. Dynamic inosinome profiles reveal novel patient stratification and gender-specific differences in glioblastoma. Genome Biol. 20, 1–18 (2019).
Article Google Scholar
Costantino, L. & Koshland, D. Genome-wide map of R-Loop-induced damage reveals how a subset of R-Loops contributes to genomic instability. Mol. Cell 71, 487–497 (2018).
Article CAS PubMed PubMed Central Google Scholar
D’Alessandro, G. et al. BRCA2 controls DNA:RNA hybrid level at DSBs by mediating RNase H2 recruitment. Nat. Commun. 9, https://www.nature.com/articles/s41467-018-07799-2 (2018).
Muse, T. G., & Aguilera, A. R Loops: from physiological to pathological roles. Cell 179, 604–618 (2019).
Article CAS Google Scholar
Ohle, C. et al. Transient RNA-DNA hybrids are required for efficient double-strand break repair. Cell 167, 1001–1013 (2016).
Article CAS PubMed Google Scholar
Zheng, Y., Lorenzo, C. & Beal, P. A. DNA editing in DNA/RNA hybrids by adenosine deaminases that act on RNA. Nucleic Acids Res. 45, 3369–3377 (2017).
CAS PubMed PubMed Central Google Scholar
Cerritelli, S. M. & Crouch, R. J. Ribonuclease H: the enzymes in eukaryotes. FEBS J. 276, 1494–1505 (2009).
Article CAS PubMed Google Scholar
García-Rubio, M., Barroso, S. I. & Aguilera, A. Detection of DNA-RNA hybrids in vivo. In Genome Instabilitys (eds. Muzi-Falconi, M. & Brown, G. W.) 347–361 (Springer, 2018).
Cristini, A., Groh, M., Kristiansen, M. S. & Gromak, N. RNA/DNA hybrid interactome identifies DXH9 as a molecular player in transcriptional termination and R-Loop-associated DNA damage. Cell Rep. 23, 1891–1905 (2018).
Article CAS PubMed PubMed Central Google Scholar
Hatchi, E. et al. BRCA1 recruitment to transcriptional pause sites is required for R-loop-driven DNA damage repair. Mol. Cell 57, 636–647 (2015).
Article CAS PubMed PubMed Central Google Scholar
Jordan Ontiveros, R., Stoute, J. & Liu, K. F. The chemical diversity of RNA modifications. Biochem. J. 476, 1227–1245 (2019).
Article PubMed Google Scholar
Abakir, A. et al. N6-methyladenosine regulates the stability of RNA:DNA hybrids in human cells. Nat. Genet. https://doi.org/10.1038/s41588-019-0549-x (2019).
Shanbhag, N. M., Metcalf, I. U. R., Bolivar, C. B., Janicki, S. M. & Greenberg, R. A. ATM-dependent chromatin changes silence transcription in cis to DNA double-strand breaks. Cell 141, 970–981 (2010).
Article CAS PubMed PubMed Central Google Scholar
Massip, L., Caron, P., Iacovoni, J. S., Trouche, D. & Legube, G. Deciphering the chromatin landscape induced around DNA double strand breaks. Cell Cycle 9, 3035–3044 (2010).
Article CAS Google Scholar
Bentley, D. L. Coupling mRNA processing with transcription in time and space. Nature reviews. Genetics 15, 163–175 (2014).
CAS PubMed Google Scholar
Liu, X. & Meng, F.-L. in Chromosome Translocation (ed. Zhang, Y.) 49–64 (Springer, 2018).
Xiang, J. F. et al. N6-Methyladenosines modulate A-to-I RNA editing. Mol. Cell 69, 126–135 (2018) .
Article CAS PubMed Google Scholar
Tassinari, V. et al. ADAR1 is a new target of METTL3 and plays a pro-oncogenic role in glioblastoma by an editing-independent mechanism. Genome Biol. 22, 1–22 (2021).
Article CAS Google Scholar
Huen, M. S. Y., Sy, S. M. H. & Chen, J. BRCA1 and its toolbox for the maintenance of genome integrity. Nat. Rev. Mol. Cell Biol. 11, 138–148 (2010).
Article CAS PubMed Google Scholar
Carvajal, R. P., Saavedra, A. L., García, C. C., Jimeno, S. & Huertas, P. Multiple roles of the splicing complex SF3B in DNA end resection and homologous recombination. DNA Repair (Amst.) 66–67, 11–23 (2018).
Article CAS Google Scholar
Carvajal, R. P., Real, G. R., Pozo, G. G. & Huertas, P. CtIP -mediated alternative mRNA splicing finetunes the DNA damage response. bioRxiv https://doi.org/10.1101/849547 (2019).
Domingo-Prim, J., Bonath, F. & Visa, N. RNA at DNA double-strand breaks: the challenge of dealing with DNA:RNA hybrids. BioEssays 42, 1–7 (2020).
Article Google Scholar
Aguilera, A. & García-Muse, T. R Loops: from transcription byproducts to threats to genome stability. Mol. Cell 46, 115–124 (2012).
Article CAS PubMed Google Scholar
Shiromoto, Y., Sakurai, M., Minakuchi, M., Ariyoshi, K. & Nishikura, K. ADAR1 RNA editing enzyme regulates R-loop formation and genome stability at telomeres in cancer cells. Nat. Commun. 12, 1654 (2021).
Bass, B. L. & Weintraub, H. A developmentally regulated activity that unwinds RNA duplexes. Cell 48, 607–613 (1987).
Article CAS PubMed Google Scholar
Bass, B. L. & Weintraub, H. An unwinding activity that covalently modifies its double-stranded RNA substrate. Cell 55, 1089–1098 (1988).
Article CAS PubMed Google Scholar
Tomaselli, S. et al. ADAR2 editing activity in newly diagnosed versus relapsed pediatric high-grade astrocytomas. BMC Cancer 13, 255 (2013).
Article CAS PubMed PubMed Central Google Scholar
Galeano, F. et al. ADAR2-editing activity inhibits glioblastoma growth through the modulation of the CDC14B/Skp2/p21/p27 axis. Oncogene 32, 998–1009 (2013).
Article CAS PubMed Google Scholar
Ten Asbroek, A. L. M. A., Van Groenigen, M., Nooij, M. & Baas, F. The involvement of human ribonucleases H1 and H2 in the variation of response of cells to antisense phosphorothioate oligonucleotides. Eur. J. Biochem. 269, 583–592 (2002).
Article PubMed Google Scholar
Pierce, A. J., Johnson, R. D., Thompson, L. H. & Jasin, M. XRCC3 promotes homology-directed repair of DNA damage in mammalian cells service XRCC3 promotes homology-directed repair of DNA damage in mammalian cells. Genes Dev. 2633–2638 (1999).
Bennardo, N., Cheng, A., Huang, N. & Stark, J. M. Alternative-NHEJ is a mechanistically distinct pathway of mammalian chromosome break repair. PLoS Genet. https://journals.plos.org/plosgenetics/article?id=10.1371/journal.pgen.1000110 (2008).
Kim, D., Paggi, J. M., Park, C., Bennett, C. & Salzberg, S. L. Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat. Biotechnol. 37, 907–915 (2019).
Article CAS PubMed PubMed Central Google Scholar
Picardi, E. & Pesole, G. REDItools: high-throughput RNA editing detection made easy. J. Bioinform. 29, 1813–1814 (2013).
Article CAS Google Scholar
Picardi, E., D’Erchia, A. M., Giudice, C. L. & Pesole, G. REDIportal: a comprehensive database of A-to-I RNA editing events in humans. Nucleic Acids Res. 45, D750–D757 (2017).
Article CAS PubMed Google Scholar

Download references

Acknowledgements

This work was funded by an R + D + I grant from the Agencia Estatal de Investigación PID2019-104195GB-I00/ AEI/10.13039/501100011033 (P.H.), R + D + I grants from the Spanish Ministry of Economy and Competitiveness (SAF2016-74855-P to P.H. and BFU2016-75058-P to A.A.), the European Research Council (ERC2014 AdG669898 TARLOOP to A.A.), the Associazione Italiana Ricerca sul Cancro-AIRC (AIRC IG 22080 to A.G.), The Swedish Research Council (grants 2015-04553 to N.V.), The Swedish Cancer Society (grant CAN 2016/460 to N.V.) and the European Union (FEDER). AR is, and FM-N and RP-C were, funded with FPU fellowships from the Spanish Ministry of Education and S.S. by a Juan de la Cierva contract from the Spanish Ministry of Economy and Competitiveness. J.D.P. and M.E-C. were supported by the Department of Molecular Biosciences, The Wenner-Gren Institute at Stockholm University. J.D-P. and R.P-C. were recipients of short-term EMBO fellowships (STF- 7513-2018 and STF-7764-2018). The mutational results shown here are in whole or part based upon the data generated by the TCGA Research Network: https://www.cancer.gov/tcga. All the bioinformatic analyses were performed using custom scripts that were run on the High performance computing cluster provided by the Centro Informático Científico de Andalucía (CICA). CABIMER is supported by the regional government of Andalucia (Junta de Andalucía).

Author information

Judit Domingo-Prim
Present address: Moirai Biodesign SL, Parc Científic de Barcelona, 08028, Barcelona, Spain
These authors contributed equally: Sonia Jimeno, Rosario Prados-Carvajal.

Authors and Affiliations

Departamento de Genética, Universidad de Sevilla, Sevilla, 41080, Spain
Sonia Jimeno, Rosario Prados-Carvajal, Sonia Silva, Guillermo Rodríguez-Real, Fernando Mejías-Navarro, Amador Romero-Franco, Silvia Jimeno-González, Sonia Barroso, Andrés Aguilera & Pablo Huertas
Centro Andaluz de Biología Molecular y Medicina Regenerativa-CABIMER, Universidad de Sevilla-CSIC-Universidad Pablo de Olavide, Sevilla, 41092, Spain
Sonia Jimeno, Rosario Prados-Carvajal, María Jesús Fernández-Ávila, Sonia Silva, Guillermo Rodríguez-Real, Fernando Mejías-Navarro, Amador Romero-Franco, Silvia Jimeno-González, Sonia Barroso, Andrés Aguilera & Pablo Huertas
RNA Editing Lab, Oncohaematology Department, IRCCS Ospedale Pediatrico “Bambino Gesù”, Viale San Paolo 15, 00146, Rome, Italy
Domenico Alessandro Silvestris, Valeriana Cesarini & Angela Gallo
Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, 10691, Stockholm, Sweden
Martín Endara-Coll, Judit Domingo-Prim & Neus Visa

Authors

Sonia Jimeno
View author publications
You can also search for this author in PubMed Google Scholar
Rosario Prados-Carvajal
View author publications
You can also search for this author in PubMed Google Scholar
María Jesús Fernández-Ávila
View author publications
You can also search for this author in PubMed Google Scholar
Sonia Silva
View author publications
You can also search for this author in PubMed Google Scholar
Domenico Alessandro Silvestris
View author publications
You can also search for this author in PubMed Google Scholar
Martín Endara-Coll
View author publications
You can also search for this author in PubMed Google Scholar
Guillermo Rodríguez-Real
View author publications
You can also search for this author in PubMed Google Scholar
Judit Domingo-Prim
View author publications
You can also search for this author in PubMed Google Scholar
Fernando Mejías-Navarro
View author publications
You can also search for this author in PubMed Google Scholar
Amador Romero-Franco
View author publications
You can also search for this author in PubMed Google Scholar
Silvia Jimeno-González
View author publications
You can also search for this author in PubMed Google Scholar
Sonia Barroso
View author publications
You can also search for this author in PubMed Google Scholar
Valeriana Cesarini
View author publications
You can also search for this author in PubMed Google Scholar
Andrés Aguilera
View author publications
You can also search for this author in PubMed Google Scholar
Angela Gallo
View author publications
You can also search for this author in PubMed Google Scholar
Neus Visa
View author publications
You can also search for this author in PubMed Google Scholar
Pablo Huertas
View author publications
You can also search for this author in PubMed Google Scholar

Contributions

S.S. and S.B. performed the analysis of DNA:RNA hybrid accumulation upon ADAR depletion at AA laboratory. V.C. created the ADAR2 cells used in the paper, and DAS analyzed the RNA seq data to calculate the recoding index, both at the AG laboratory. M.E.-C. and J.D.-P. performed the laser microirradiation experiments at the NV laboratory. A.R.-F. performed the in silico analysis of DNA mutations associated to ADAR levels in tumor samples. MF-A analysed first the resection defect of ADAR depleted cells. G.R.-R. performed RNA editing experiments in the presence of an inhibitor and tested the effect of RNase H overexpression in the DR-GFP upon ADAR depletion. F.M.-N. analyzed resection by SMART upon ADAR depletion. S.J.-G. collaborates with the interpretation of some genome-wide experiments. The rest of the experiments were performed by SJ and RP-C. S.J. and P.H. directed the work and coordinate the people involved. P.H. wrote the manuscript.

Corresponding authors

Correspondence to Sonia Jimeno or Pablo Huertas.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Peer review information Nature Communications thanks the anonymous reviewer(s) for their contribution to the peer review of this work.

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Supplementary Information

Description of Additional Supplementary Files

Supplementary Data 1

Reporting Summary

Source data

Source Data

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Cite this article

Jimeno, S., Prados-Carvajal, R., Fernández-Ávila, M.J. et al. ADAR-mediated RNA editing of DNA:RNA hybrids is required for DNA double strand break repair. Nat Commun 12, 5512 (2021). https://doi.org/10.1038/s41467-021-25790-2

Download citation

Received: 09 May 2020
Accepted: 23 August 2021
Published: 17 September 2021
DOI: https://doi.org/10.1038/s41467-021-25790-2

This article is cited by

RNA modification in cardiovascular disease: implications for therapeutic interventions
- Cong Wang
- Xuyang Hou
- Haidan Liu
Signal Transduction and Targeted Therapy (2023)
Evolutionary honing in and mutational replacement: how long-term directed mutational responses to specific environmental pressures are possible
- Adi Livnat
- Daniel Melamed
Theory in Biosciences (2023)
Sources, resolution and physiological relevance of R-loops and RNA–DNA hybrids
- Eva Petermann
- Li Lan
- Lee Zou
Nature Reviews Molecular Cell Biology (2022)
ADAR3 activates NF-κB signaling and promotes glioblastoma cell resistance to temozolomide
- Reshma Raghava Kurup
- Eimile K. Oakes
- Heather A. Hundley
Scientific Reports (2022)
Breakage of cytoplasmic chromosomes by pathological DNA base excision repair
- Shangming Tang
- Ema Stokasimov
- David Pellman
Nature (2022)

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.